Literature DB >> 19214293

Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials.

Jonathan G Howlett1, Robert S McKelvie, J Malcolm O Arnold, Jeannine Costigan, Paul Dorian, Anique Ducharme, Estrellita Estrella-Holder, Justin A Ezekowitz, Nadia Giannetti, Haissam Haddad, George A Heckman, Anthony M Herd, Debra Isaac, Philip Jong, Simon Kouz, Peter Liu, Elizabeth Mann, Gordon W Moe, Ross T Tsuyuki, Heather J Ross, Michel White.   

Abstract

The Canadian Cardiovascular Society published a comprehensive set of recommendations on the diagnosis and management of heart failure in January 2006. Based on feedback obtained through a national program of heart failure workshops and through active solicitation of stakeholders, several topics were identified because of their importance to the practicing clinician. Topics chosen for the present update include best practices for the diagnosis and management of right-sided heart failure, myocarditis and device therapy, and a review of recent important or landmark clinical trials. These recommendations were developed using the structured approach for the review and assessment of evidence adopted and previously described by the Society. The present update has been written from a clinical perspective to provide a user-friendly and practical approach. Specific clinical questions that are addressed include: What is right-sided heart failure and how should one approach the diagnostic work-up? What other clinical entities may masquerade as this nebulous condition and how can we tell them apart? When should we be concerned about the presence of myocarditis and how quickly should patients with this condition be referred to an experienced centre? Among the myriad of recently published landmark clinical trials, which ones will impact our standards of clinical care? The goals are to aid physicians and other health care providers to optimally treat heart failure patients, resulting in a measurable impact on patient health and clinical outcomes in Canada.

Entities:  

Mesh:

Year:  2009        PMID: 19214293      PMCID: PMC2691911          DOI: 10.1016/s0828-282x(09)70477-5

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  134 in total

1.  Intravenous iron alone for the treatment of anemia in patients with chronic heart failure.

Authors:  Aidan P Bolger; Frederick R Bartlett; Helen S Penston; Justin O'Leary; Noel Pollock; Raffi Kaprielian; Callum M Chapman
Journal:  J Am Coll Cardiol       Date:  2006-08-28       Impact factor: 24.094

2.  Statins and chronic heart failure: do we need a large-scale outcome trial?

Authors:  Henry Krum; John J McMurray
Journal:  J Am Coll Cardiol       Date:  2002-05-15       Impact factor: 24.094

3.  Constrictive pericarditis: A reminder of a not so rare disease.

Authors:  Michael Bergman; Janos Vitrai; Hertzel Salman
Journal:  Eur J Intern Med       Date:  2006-11       Impact factor: 4.487

Review 4.  Constrictive pericarditis in 26 patients with histologically normal pericardial thickness.

Authors:  Deepak R Talreja; William D Edwards; Gordon K Danielson; Hartzell V Schaff; A Jamil Tajik; Henry D Tazelaar; Jerome F Breen; Jae K Oh
Journal:  Circulation       Date:  2003-09-29       Impact factor: 29.690

Review 5.  Atrial fibrillation in patients with congestive heart failure.

Authors:  Bradley P Knight
Journal:  Pacing Clin Electrophysiol       Date:  2003-07       Impact factor: 1.976

6.  Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Eric P Leip; Philip A Wolf; Ralph B D'Agostino; Joanne M Murabito; William B Kannel; Emelia J Benjamin
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

7.  Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Authors:  Domenico Corrado; Loira Leoni; Mark S Link; Paolo Della Bella; Fiorenzo Gaita; Antonio Curnis; Jorge Uriarte Salerno; Diran Igidbashian; Antonio Raviele; Marcello Disertori; Gabriele Zanotto; Roberto Verlato; Giuseppe Vergara; Pietro Delise; Pietro Turrini; Cristina Basso; Franco Naccarella; Francesco Maddalena; N A Mark Estes; Gianfranco Buja; Gaetano Thiene
Journal:  Circulation       Date:  2003-11-24       Impact factor: 29.690

8.  Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  Darshan Dalal; Rahul Jain; Harikrishna Tandri; Jun Dong; Shaker M Eid; Kalpana Prakasa; Crystal Tichnell; Cynthia James; Theodore Abraham; Stuart D Russell; Sunil Sinha; Daniel P Judge; David A Bluemke; Joseph E Marine; Hugh Calkins
Journal:  J Am Coll Cardiol       Date:  2007-07-16       Impact factor: 24.094

9.  Biventricular pacing: impact on exercise-induced increases in mitral insufficiency in patients with chronic heart failure.

Authors:  Klaus K Witte; Zion Sasson; Joan A Persaud; Robynn Jolliffe; Robert W Wald; John D Parker
Journal:  Can J Cardiol       Date:  2008-05       Impact factor: 5.223

10.  Familial effort polymorphic ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy map to chromosome 1q42-43.

Authors:  B Bauce; A Nava; A Rampazzo; L Daliento; M Muriago; C Basso; G Thiene; G A Danieli
Journal:  Am J Cardiol       Date:  2000-03-01       Impact factor: 2.778

View more
  21 in total

1.  Underrepresentation of individuals 80 years of age and older in chronic disease clinical practice guidelines.

Authors:  Lizebeth Cox; Marita Kloseck; Richard Crilly; Carol McWilliam; Laura Diachun
Journal:  Can Fam Physician       Date:  2011-07       Impact factor: 3.275

Review 2.  Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine.

Authors:  Domenico De Berardis; Gabriella Rapini; Luigi Olivieri; Domenico Di Nicola; Carmine Tomasetti; Alessandro Valchera; Michele Fornaro; Fabio Di Fabio; Giampaolo Perna; Marco Di Nicola; Gianluca Serafini; Alessandro Carano; Maurizio Pompili; Federica Vellante; Laura Orsolini; Giovanni Martinotti; Massimo Di Giannantonio
Journal:  Ther Adv Drug Saf       Date:  2018-02-06

Review 3.  Role of cardiac MRI and nuclear imaging in cardiac resynchronization therapy.

Authors:  Niti R Aggarwal; Matthew W Martinez; Bernard J Gersh; Panithaya Chareonthaitawee
Journal:  Nat Rev Cardiol       Date:  2009-11-03       Impact factor: 32.419

Review 4.  Effective communication and ethical consent in decisions related to ICDs.

Authors:  Alexander M Clark; Tiny Jaarsma; Patricia Strachan; Patricia M Davidson; Megan Jerke; James M Beattie; Amanda S Duncan; Chantal F Ski; David R Thompson
Journal:  Nat Rev Cardiol       Date:  2011-07-26       Impact factor: 32.419

Review 5.  The timing of implantable cardioverter-defibrillator implantation in patients with heart failure.

Authors:  Nawaf S Al-Majed; Justin A Ezekowitz
Journal:  Curr Cardiol Rep       Date:  2012-06       Impact factor: 2.931

Review 6.  Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status.

Authors:  Terry K W Ma; Kevin K H Kam; Bryan P Yan; Yat-Yin Lam
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

Review 7.  Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance.

Authors:  A Mebazaa; H Tolppanen; C Mueller; J Lassus; S DiSomma; G Baksyte; M Cecconi; D J Choi; A Cohen Solal; M Christ; J Masip; M Arrigo; S Nouira; D Ojji; F Peacock; M Richards; N Sato; K Sliwa; J Spinar; H Thiele; M B Yilmaz; J Januzzi
Journal:  Intensive Care Med       Date:  2015-09-14       Impact factor: 17.440

8.  A Challenging Case Of Ventricular Arrhythmia In A Patient With Myocarditis: ICD Yes/No After Ablation.

Authors:  Maria L Narducci; Teresa Rio; Francesco Perna; Domenico D'Amario; Biagio Merlino; Riccardo Marano; Gianluigi Bencardino; Frediano Inzani; Gemma Pelargonio; Filippo Crea
Journal:  J Atr Fibrillation       Date:  2014-10-31

Review 9.  Noninvasive risk stratification after myocardial infarction: rationale, current evidence and the need for definitive trials.

Authors:  Derek Exner
Journal:  Can J Cardiol       Date:  2009-06       Impact factor: 5.223

10.  A Case of Dilated Cardiomyopathy Associated with 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG CoA) Lyase Deficiency.

Authors:  Alexander A C Leung; Alicia K Chan; Justin A Ezekowitz; Alexander K C Leung
Journal:  Case Rep Med       Date:  2009-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.